HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU phasing in animal testing ban

This article was originally published in The Rose Sheet

Executive Summary

The European Union's phased ban on animal testing went into effect March 11. The measures, which ban testing on animals to assess the safety of cosmetic ingredients and will eventually ban the sale of cosmetics containing ingredients tested on animals, were enacted in 2003 with the intention of going on-line this year. The animal-tested products ban has been pushed back to March 2013 to allow time for scientific progress in the development of in vitro alternatives. The European Commission will assess the state of the science in 2011. The ban represents a "tremendous scientific challenge" for industry, according to the European Cosmetics Association (Colipa); however, "our industry's commitment to replacing animal testing stretches back long before bans were put in place. We play a leading role in the development of new alternative methods and will continue to work together with other key partners, in order to move towards the goal of replacing animal testing completely," says Colipa Director-General Bertil Heerink. Industry has launched a joint research initiative with the European Commission to develop alternative testing strategies, Colipa says. According to the Personal Care Products Council, major U.S. firms are prepared for the ban (1"The Rose Sheet" June 9, 2008, p. 3)

You may also be interested in...

Industry Investment Needed Toward Alternative Tests For Thornier Endpoints

There is critical need for development of non-animal testing strategies to assess cancer and reproductive toxicity, says Meglena Kuneva, European Union commissioner for consumer affairs

Major U.S. Cosmetic Firms Say They Are Ready For Animal Test Ban In EU

The EU's upcoming ban on products tested on animals could affect the availability of some novel cosmetic ingredients, though it is unlikely to have a jarring impact on large U.S. personal-care marketers

Falling At The Start Line: Chinese Firms Face Multiple Commercial Challenges Beyond Price, Coverage

Sales of a global first-in-class dermatology drug that gained its first approval in China are falling well behind those of its overseas counterpart. In this case study, Scrip takes a deep dive into the multiple underlying factors determining success in the world's second-largest pharma market beyond pricing and reimbursement coverage, including complex hospital entry, dual channels and competition considerations. 

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts